Literature DB >> 9386966

A systematic survey of caffeine intake in Vermont.

J R Hughes1, A H Oliveto.   

Abstract

Detailed data were collected on lifetime caffeine intake from 202 Vermont residents using a random-digit dial telephone survey. The sample appeared representative and test-retest reliability of caffeine intake was high (r = .95). Almost all participants (96%) had ever used and most (83%) presently used one or more caffeinated beverages weekly. The average caffeine intake was 186 mg/day. Many caffeine users (61%) used caffeinated beverages other than coffee. Current caffeine intake was a poor measure of lifetime intake. For example, among ever-users of caffeine, 41% had stopped at least 1 type of caffeinated beverage and 14% had stopped caffeine altogether. Cessation was mostly due to health concerns and unpleasant side effects. It was concluded that simply asking about "usual" coffee use is a poor and biased estimate of lifetime caffeine use. Thus, prior findings that caffeine is not associated with medical or behavioral disorders may represent false-negative results.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9386966     DOI: 10.1037//1064-1297.5.4.393

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  13 in total

1.  Cortisol responses to mental stress, exercise, and meals following caffeine intake in men and women.

Authors:  William R Lovallo; Noha H Farag; Andrea S Vincent; Terrie L Thomas; Michael F Wilson
Journal:  Pharmacol Biochem Behav       Date:  2006-05-02       Impact factor: 3.533

Review 2.  A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features.

Authors:  Laura M Juliano; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2004-09-21       Impact factor: 4.530

Review 3.  Caffeine use in children: what we know, what we have left to learn, and why we should worry.

Authors:  Jennifer L Temple
Journal:  Neurosci Biobehav Rev       Date:  2009-01-20       Impact factor: 8.989

4.  Characterization of individuals seeking treatment for caffeine dependence.

Authors:  Laura M Juliano; Daniel P Evatt; Brian D Richards; Roland R Griffiths
Journal:  Psychol Addict Behav       Date:  2012-02-27

5.  Adenosine A1 and A2A receptors are not upstream of caffeine's dopamine D2 receptor-dependent aversive effects and dopamine-independent rewarding effects.

Authors:  Jessica E Sturgess; Ryan A Ting-A-Kee; Dominik Podbielski; Laurie H L Sellings; Jiang-Fan Chen; Derek van der Kooy
Journal:  Eur J Neurosci       Date:  2010-06-22       Impact factor: 3.386

6.  Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis.

Authors:  M Heliövaara; K Aho; P Knekt; O Impivaara; A Reunanen; A Aromaa
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

7.  Clinical and physiological correlates of caffeine and caffeine metabolites in primary insomnia.

Authors:  Mark R Youngberg; Irina O Karpov; Amy Begley; Bruce G Pollock; Daniel J Buysse
Journal:  J Clin Sleep Med       Date:  2011-04-15       Impact factor: 4.062

8.  Fourteen well-described caffeine withdrawal symptoms factor into three clusters.

Authors:  Stephen Ozsungur; Darren Brenner; Ahmed El-Sohemy
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

9.  Caffeine consumption, sleep, and affect in the natural environments of depressed youth and healthy controls.

Authors:  Diana J Whalen; Jennifer S Silk; Mara Semel; Erika E Forbes; Neal D Ryan; David A Axelson; Boris Birmaher; Ronald E Dahl
Journal:  J Pediatr Psychol       Date:  2007-10-18

10.  Methodological considerations for the quantification of self-reported caffeine use.

Authors:  Merideth A Addicott; Lucie L Yang; Ann M Peiffer; Paul J Laurienti
Journal:  Psychopharmacology (Berl)       Date:  2008-11-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.